Industry: Medical Devices & Consumables
Published Date: 2026-03-26
Pages: 73 Pages
Report ld: 6367978
Request Sample
Customized Report
The global Single Channel Deep Brain Stimulation (DBS) Devices market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the treatment of movement and neuropsychiatric disorders. DBS in select brain regions has provided therapeutic benefits for otherwise-treatment-resistant disorders such as Parkinson's disease, essential tremor, dystonia, chronic pain, major depression and obsessive–compulsive disorder (OCD). Despite the long history of DBS, its underlying principles and mechanisms are still not clear. DBS directly changes brain activity in a controlled manner, its effects are reversible (unlike those of lesioning techniques), and it is one of only a few neurosurgical methods that allow blinded studies.
A single-channel deep brain stimulation device offers a sophisticated solution for managing neurological disorders by delivering precise electrical stimulation to specific brain regions. The system's effectiveness depends on meticulous planning, accurate implantation, and continuous monitoring and adjustment to tailor the therapy to each patient's unique needs. Regular follow-ups and maintenance are essential to ensure the device's long-term efficacy and safety.
The global Single Channel Deep Brain Stimulation (DBS) Devices market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Single Channel Deep Brain Stimulation (DBS) Devices sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Single Channel Deep Brain Stimulation (DBS) Devices manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Single Channel Deep Brain Stimulation (DBS) Devices product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Single Channel Deep Brain Stimulation (DBS) Devices value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Single Channel Deep Brain Stimulation (DBS) Devices Product Scope
1.2 Single Channel Deep Brain Stimulation (DBS) Devices by Type
1.2.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Sales by Type (2021, 2025 & 2032)
1.2.2 Rechargeable DBS
1.2.3 Non-rechargeable DBS
1.3 Single Channel Deep Brain Stimulation (DBS) Devices by Application
1.3.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Parkinson's Disease
1.3.3 Essential Tremor
1.3.4 Dystonia
1.3.5 Others
1.4 Global Single Channel Deep Brain Stimulation (DBS) Devices Market Estimates and Forecasts (2021-2032)
1.4.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Single Channel Deep Brain Stimulation (DBS) Devices Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Single Channel Deep Brain Stimulation (DBS) Devices Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Single Channel Deep Brain Stimulation (DBS) Devices Historical Market Scenario by Region (2021-2026)
2.2.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Sales Market Share by Region (2021-2026)
2.2.2 Global Single Channel Deep Brain Stimulation (DBS) Devices Revenue Market Share by Region (2021-2026)
2.3 Global Single Channel Deep Brain Stimulation (DBS) Devices Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Single Channel Deep Brain Stimulation (DBS) Devices Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Single Channel Deep Brain Stimulation (DBS) Devices Market Size and Prospects (2021-2032)
2.4.2 Europe Single Channel Deep Brain Stimulation (DBS) Devices Market Size and Prospects (2021-2032)
2.4.3 China Single Channel Deep Brain Stimulation (DBS) Devices Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Historical Market Review by Type (2021-2026)
3.1.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Sales by Type (2021-2026)
3.1.2 Global Single Channel Deep Brain Stimulation (DBS) Devices Revenue by Type (2021-2026)
3.1.3 Global Single Channel Deep Brain Stimulation (DBS) Devices Average Price by Type (2021-2026)
3.2 Global Single Channel Deep Brain Stimulation (DBS) Devices Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Sales Forecast by Type (2027-2032)
3.2.2 Global Single Channel Deep Brain Stimulation (DBS) Devices Revenue Forecast by Type (2027-2032)
3.2.3 Global Single Channel Deep Brain Stimulation (DBS) Devices Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Single Channel Deep Brain Stimulation (DBS) Devices
4 Global Market Size by Application
4.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Historical Market Review by Application (2021-2026)
4.1.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Sales by Application (2021-2026)
4.1.2 Global Single Channel Deep Brain Stimulation (DBS) Devices Revenue by Application (2021-2026)
4.1.3 Global Single Channel Deep Brain Stimulation (DBS) Devices Average Price by Application (2021-2026)
4.2 Global Single Channel Deep Brain Stimulation (DBS) Devices Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Sales Forecast by Application (2027-2032)
4.2.2 Global Single Channel Deep Brain Stimulation (DBS) Devices Revenue Forecast by Application (2027-2032)
4.2.3 Global Single Channel Deep Brain Stimulation (DBS) Devices Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Single Channel Deep Brain Stimulation (DBS) Devices Applications
5 Competition Landscape by Players
5.1 Global Single Channel Deep Brain Stimulation (DBS) Devices Sales by Player (2021-2026)
5.2 Global Top Single Channel Deep Brain Stimulation (DBS) Devices Players by Revenue (2021-2026)
5.3 Global Single Channel Deep Brain Stimulation (DBS) Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Single Channel Deep Brain Stimulation (DBS) Devices revenue as of 2025
5.4 Global Single Channel Deep Brain Stimulation (DBS) Devices Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Single Channel Deep Brain Stimulation (DBS) Devices, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Single Channel Deep Brain Stimulation (DBS) Devices, Product Type & Application
5.7 Global Key Manufacturers of Single Channel Deep Brain Stimulation (DBS) Devices, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Single Channel Deep Brain Stimulation (DBS) Devices Sales by Company
6.1.1.1 North America Single Channel Deep Brain Stimulation (DBS) Devices Sales by Company (2021-2026)
6.1.1.2 North America Single Channel Deep Brain Stimulation (DBS) Devices Revenue by Company (2021-2026)
6.1.2 North America Single Channel Deep Brain Stimulation (DBS) Devices Sales Breakdown by Type (2021-2026)
6.1.3 North America Single Channel Deep Brain Stimulation (DBS) Devices Sales Breakdown by Application (2021-2026)
6.1.4 North America Single Channel Deep Brain Stimulation (DBS) Devices Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Single Channel Deep Brain Stimulation (DBS) Devices Sales by Company
6.2.1.1 Europe Single Channel Deep Brain Stimulation (DBS) Devices Sales by Company (2021-2026)
6.2.1.2 Europe Single Channel Deep Brain Stimulation (DBS) Devices Revenue by Company (2021-2026)
6.2.2 Europe Single Channel Deep Brain Stimulation (DBS) Devices Sales Breakdown by Type (2021-2026)
6.2.3 Europe Single Channel Deep Brain Stimulation (DBS) Devices Sales Breakdown by Application (2021-2026)
6.2.4 Europe Single Channel Deep Brain Stimulation (DBS) Devices Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Single Channel Deep Brain Stimulation (DBS) Devices Sales by Company
6.3.1.1 China Single Channel Deep Brain Stimulation (DBS) Devices Sales by Company (2021-2026)
6.3.1.2 China Single Channel Deep Brain Stimulation (DBS) Devices Revenue by Company (2021-2026)
6.3.2 China Single Channel Deep Brain Stimulation (DBS) Devices Sales Breakdown by Type (2021-2026)
6.3.3 China Single Channel Deep Brain Stimulation (DBS) Devices Sales Breakdown by Application (2021-2026)
6.3.4 China Single Channel Deep Brain Stimulation (DBS) Devices Major Customers
6.3.5 China Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Medtronic
7.1.1 Medtronic Company Information
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Single Channel Deep Brain Stimulation (DBS) Devices Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Medtronic Single Channel Deep Brain Stimulation (DBS) Devices Products Offered
7.1.5 Medtronic Recent Development
7.2 Boston Scientific
7.2.1 Boston Scientific Company Information
7.2.2 Boston Scientific Business Overview
7.2.3 Boston Scientific Single Channel Deep Brain Stimulation (DBS) Devices Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Boston Scientific Single Channel Deep Brain Stimulation (DBS) Devices Products Offered
7.2.5 Boston Scientific Recent Development
7.3 Abbott
7.3.1 Abbott Company Information
7.3.2 Abbott Business Overview
7.3.3 Abbott Single Channel Deep Brain Stimulation (DBS) Devices Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Abbott Single Channel Deep Brain Stimulation (DBS) Devices Products Offered
7.3.5 Abbott Recent Development
7.4 Beijing Pins
7.4.1 Beijing Pins Company Information
7.4.2 Beijing Pins Business Overview
7.4.3 Beijing Pins Single Channel Deep Brain Stimulation (DBS) Devices Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Beijing Pins Single Channel Deep Brain Stimulation (DBS) Devices Products Offered
7.4.5 Beijing Pins Recent Development
7.5 SceneRay
7.5.1 SceneRay Company Information
7.5.2 SceneRay Business Overview
7.5.3 SceneRay Single Channel Deep Brain Stimulation (DBS) Devices Sales, Revenue and Gross Margin (2021-2026)
7.5.4 SceneRay Single Channel Deep Brain Stimulation (DBS) Devices Products Offered
7.5.5 SceneRay Recent Development
8 Single Channel Deep Brain Stimulation (DBS) Devices Manufacturing Cost Analysis
8.1 Single Channel Deep Brain Stimulation (DBS) Devices Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Single Channel Deep Brain Stimulation (DBS) Devices
8.4 Single Channel Deep Brain Stimulation (DBS) Devices Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Single Channel Deep Brain Stimulation (DBS) Devices Distributors List
9.3 Single Channel Deep Brain Stimulation (DBS) Devices Customers
10 Single Channel Deep Brain Stimulation (DBS) Devices Market Dynamics
10.1 Single Channel Deep Brain Stimulation (DBS) Devices Industry Trends
10.2 Single Channel Deep Brain Stimulation (DBS) Devices Market Drivers
10.3 Single Channel Deep Brain Stimulation (DBS) Devices Market Challenges
10.4 Single Channel Deep Brain Stimulation (DBS) Devices Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Single Channel Deep Brain Stimulation (DBS) Devices market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 116
USD 4900.00
(Single User License)
The global market for Single Channel Deep Brain Stimulation (DBS) Devices was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 81
USD 3950.00
(Single User License)
The global Single Channel Deep Brain Stimulation (DBS) Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-15
Pages: 100
USD 2900.00
(Single User License)
The global Single Channel Deep Brain Stimulation (DBS) Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 127
USD 4900.00
(Single User License)
The global Single Channel Deep Brain Stimulation (DBS) Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 75
USD 4250.00
(Single User License)
The global market for Single Channel Deep Brain Stimulation (DBS) Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 90
USD 3950.00
(Single User License)
The global market for Single Channel Deep Brain Stimulation (DBS) Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 68
USD 2900.00
(Single User License)
Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the treatment of movement and neuropsychiatric disorders. DBS in select brain regions has provided therapeutic benefits for otherwise-treatment-resistant disorders such as Parkinson's disease, essential tremor, dystonia, chronic pain, major depression and obsessive–compulsive disorder (OCD). Despite the long history of DBS, its underlying principles and mechanisms are still not clear. DBS directly changes brain activity in a controlled manner, its effects are reversible (unlike those of lesioning techniques), and it is one of only a few neurosurgical methods that allow blinded studies.
Published Date: 2024-06-27
Pages: 70
USD 2900.00
(Single User License)
Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the treatment of movement and neuropsychiatric disorders. DBS in select brain regions has provided therapeutic benefits for otherwise-treatment-resistant disorders such as Parkinson's disease, essential tremor, dystonia, chronic pain, major depression and obsessive–compulsive disorder (OCD). Despite the long history of DBS, its underlying principles and mechanisms are still not clear. DBS directly changes brain activity in a controlled manner, its effects are reversible (unlike those of lesioning techniques), and it is one of only a few neurosurgical methods that allow blinded studies.
Published Date: 2024-06-27
Pages: 94
USD 4350.00
(Single User License)
Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the treatment of movement and neuropsychiatric disorders. DBS in select brain regions has provided therapeutic benefits for otherwise-treatment-resistant disorders such as Parkinson's disease, essential tremor, dystonia, chronic pain, major depression and obsessive–compulsive disorder (OCD). Despite the long history of DBS, its underlying principles and mechanisms are still not clear. DBS directly changes brain activity in a controlled manner, its effects are reversible (unlike those of lesioning techniques), and it is one of only a few neurosurgical methods that allow blinded studies.
Published Date: 2024-06-27
Pages: 125
USD 4900.00
(Single User License)
The global Single Channel Deep Brain Stimulation (DBS) Devices market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 116
The global market for Single Channel Deep Brain Stimulation (DBS) Devices was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 81
The global Single Channel Deep Brain Stimulation (DBS) Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 100
The global Single Channel Deep Brain Stimulation (DBS) Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 127
The global Single Channel Deep Brain Stimulation (DBS) Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 75
The global market for Single Channel Deep Brain Stimulation (DBS) Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 90
The global market for Single Channel Deep Brain Stimulation (DBS) Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 68
Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the treatment of movement and neuropsychiatric disorders. DBS in select brain regions has provided therapeutic benefits for otherwise-treatment-resistant disorders such as Parkinson's disease, essential tremor, dystonia, chronic pain, major depression and obsessive–compulsive disorder (OCD). Despite the long history of DBS, its underlying principles and mechanisms are still not clear. DBS directly changes brain activity in a controlled manner, its effects are reversible (unlike those of lesioning techniques), and it is one of only a few neurosurgical methods that allow blinded studies.
Published: 2024-06-27
Pages: 70
Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the treatment of movement and neuropsychiatric disorders. DBS in select brain regions has provided therapeutic benefits for otherwise-treatment-resistant disorders such as Parkinson's disease, essential tremor, dystonia, chronic pain, major depression and obsessive–compulsive disorder (OCD). Despite the long history of DBS, its underlying principles and mechanisms are still not clear. DBS directly changes brain activity in a controlled manner, its effects are reversible (unlike those of lesioning techniques), and it is one of only a few neurosurgical methods that allow blinded studies.
Published: 2024-06-27
Pages: 94
Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the treatment of movement and neuropsychiatric disorders. DBS in select brain regions has provided therapeutic benefits for otherwise-treatment-resistant disorders such as Parkinson's disease, essential tremor, dystonia, chronic pain, major depression and obsessive–compulsive disorder (OCD). Despite the long history of DBS, its underlying principles and mechanisms are still not clear. DBS directly changes brain activity in a controlled manner, its effects are reversible (unlike those of lesioning techniques), and it is one of only a few neurosurgical methods that allow blinded studies.
Published: 2024-06-27
Pages: 125
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now